Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Laurion Capital Management LP | 3.10M | $4.0M | 4.52% | +451.6K | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.90M | $3.0M | 4.23% | +39.6K | 2026-06-30 |
| Pfizer Inc | 2.41M | $3.0M | 3.52% | -- | 2026-06-30 |
| FRANKLIN RESOURCES INC | 1.21M | $1.0M | 1.76% | -- | 2026-06-30 |
| BlackRock, Inc. | 972.9K | $1.0M | 1.42% | -3.01M | 2026-06-30 |
| BLAIR WILLIAM & CO/IL | 912.5K | $1.0M | 1.33% | -9.9K | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 820.1K | $1.0M | 1.20% | -779.6K | 2026-06-30 |
| JANE STREET GROUP, LLC | 688.9K | -- | 1.01% | +648.8K | 2026-06-30 |
| UBS Group AG | 638.7K | -- | 0.93% | +238.1K | 2026-06-30 |
| VANGUARD FIDUCIARY TRUST CO | 410.6K | -- | 0.60% | -35.6K | 2026-06-30 |
